4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-028109
Chief Medical Officer sold 50,000 shares at an average $33.86 ($1,692,885)
- Chief Medical Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BALDO LANCE Chief Medical Officer | 2020-05-06 | Option exercise | +50,000 | $7.80 | $390,000 | 50,000 | D |
| BALDO LANCE Chief Medical Officer | 2020-05-06 | Sale | −49,450 | $33.85 | $1,673,883 | 550 | D |
| BALDO LANCE Chief Medical Officer | 2020-05-06 | Sale | −550 | $34.55 | $19,003 | 0 | D |
| Derivatives | |||||||
| BALDO LANCE Chief Medical Officer | 2020-05-06 | Option exercise · Stock Option (Right to Buy) | −50,000 | 450,000 | D | ||
| Open-market sales · 50,000 sh · avg $33.86 · $1,692,885 | |||||||
Loading xslF345X03/doc4.xml…